Organogenesis
ORGO
$2.35
Share price
2.84%
Change (1 day)
14.63%
Change (1 year)
Categories
Organogenesis (ORGO) - Total assets
Total assets on the balance sheet as of December 2023 : $0.46 B
According to Organogenesis's latest financial reports the company's total assets are $0.46 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Organogenesis - Total assets on balance sheet (from 2016 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.46 B | 2.37% |
| 2022-12-31 | $0.44 B | 1.38% |
| 2021-12-31 | $0.44 B | 52.73% |
| 2020-12-31 | $0.29 B | 31.51% |
| 2019-12-31 | $0.22 B | 34.83% |
| 2018-12-31 | $0.16 B | 10.06% |
| 2017-12-31 | $0.14 B | -52.25% |
| 2016-12-31 | $0.31 B | 74715.66% |
| 2015-12-31 | $0.41 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $2.01 B | 337.30% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $22.68 M | -95.07% | 🇺🇸 USA |